N/A N=11 Prevention

A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants

Healthy, no Evidence of Disease

Bottom Line

View on ClinicalTrials.gov: NCT00768118 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2014

Primary outcome: Primary: The Magnitude of Change in Blood Lymphocyte NF-kB Level — -40.51 Optical Density unit

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: curcumin/green tea extract/Polygonum cuspidatum extract/soybean extract capsule (Dietary_supplement); electrophoretic mobility shift assay (Genetic); laboratory biomarker analysis (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Barbara Ann Karmanos Cancer Institute
Primary completion: Sep 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY The Magnitude of Change in Blood Lymphocyte NF-kB Level	-40.51	—

Summary

RATIONALE: Studying samples of blood and urine from healthy participants receiving antioxidant nutritional supplements may help doctors identify changes in biomarkers related to oxidative stress. PURPOSE: This clinical trial is studying how well a nutritional supplement capsule containing curcumin, green tea extract, Polygonum cuspidatum extract, and soybean extract works in healthy participants.

Eligibility Criteria

DISEASE CHARACTERISTICS:

Healthy volunteers who are employees of Karmanos Cancer Institute, Wayne State University, or Detroit Medical Center

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

Not specified

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00768118). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.